Cargando…
Metabolomic Biomarkers in Anxiety Disorders
Anxiety disorders range among the most prevalent psychiatric disorders and belong to the leading disorders in the study of the total global burden of disease. Anxiety disorders are complex conditions, with not fully understood etiological mechanisms. Numerous factors, including psychological, geneti...
Autores principales: | Humer, Elke, Pieh, Christoph, Probst, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369790/ https://www.ncbi.nlm.nih.gov/pubmed/32640734 http://dx.doi.org/10.3390/ijms21134784 |
Ejemplares similares
-
Metabolomics in Psychiatric Disorders: What We Learn from Animal Models
por: Humer, Elke, et al.
Publicado: (2020) -
Metabolomics in Sleep, Insomnia and Sleep Apnea
por: Humer, Elke, et al.
Publicado: (2020) -
Being a Psychotherapist in Times of the Novel Coronavirus Disease: Stress-Level, Job Anxiety, and Fear of Coronavirus Disease Infection in More Than 1,500 Psychotherapists in Austria
por: Probst, Thomas, et al.
Publicado: (2020) -
Comparing Mental Health During the COVID-19 Lockdown and 6 Months After the Lockdown in Austria: A Longitudinal Study
por: Pieh, Christoph, et al.
Publicado: (2021) -
Diminished well-being persists beyond the end of the COVID-19 lockdown
por: Pieh, Christoph, et al.
Publicado: (2021)